Abstract:Hiroki Teragawa, Yuko Uchimura, Chikage Oshita, Yu Hashimoto, Shuichi Nomura Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan Correspondence: Hiroki Teragawa, Department of Cardiovascular Medicine, JR Hiroshima Hospital, 3-1-36 Futabanosato, Higashi-ku, Hiroshima, 732-0057, Japan, Tel +81 82 262 1171, Fax +81 82 262 1499, Email Purpose: The clinical background and prognostic impact of diabetes mellitus (DM) on vasospastic angina (VSA) are unclear; thus, in this retrospective study, we investigated whether they differ based on the presence or absence of DM in patients with VSA. Patients and Methods: We included 272 Japanese patients with VSA diagnosed by coronary angiography (CAG) and the spasm provocation test (SPT). The diagnosis of DM was determined by measuring fasting blood glucose and hemoglobin A1C and by the patient's current oral medications. On CAG, the presence of atherosclerotic lesions (20%– 50%) was checked. On SPT, the coronary spasm was defined as transient coronary vasoconstriction > 90% on CAG, accompanied by chest symptoms and/or ST-T changes. Focal spasm was defined as coronary spasm occurring within one segment of the American Heart Association classification on CAG. Blood and urine tests and vascular endothelial function were also evaluated when possible. A major adverse cardiovascular event (MACE), which is defined as cardiac mortality and rehospitalization due to cardiovascular illness, was the basis for determining the prognosis. Results: There were 49 patients (18%) in the DM group and 223 (82%) in the non-DM group. No significant differences in urinary albumin levels and peripheral vascular function were between groups. On CAG, atherosclerotic lesions were observed significantly more frequently in the DM group (63% vs 46%; P = 0.028). Results of SPT showed a trend toward fewer focal spasms in the DM group (24% vs 39%; P = 0.072). No significant differences in MACE were noted between groups in the primary analysis of DM, whereas sub-analyses of focal spasms showed lower MACE-free survival in the DM group (P = 0.042). Conclusion: The study results support the hypothesis that DM associated with VSA should be treated appropriately, especially in cases of focal spasm, which may require more attention in treatment. Keywords: atherosclerotic change, coronary spasm, coronary spastic angina, diabetes mellitus, focal spasm Transient vasoconstriction of the epicardial coronary arteries causes myocardial ischemia in patients with vasospastic angina (VSA). 1–3 Like exertional or resting angina, acute coronary syndromes, heart failure, and sudden cardiac death are all largely attributed to coronary spasm. 4–6 Recently, more studies have focused on both angina with non-obstructive coronary artery disease (ANOCA) and/or myocardial infarction with non-obstructive coronary arteries (MINOCA), which causes chest pain and myocardial damage without significant coronary artery stenosis. One of the main causes of these diseases is VSA, for which the etiology, diagnosis, and treatment are increasingly being investigated. VSA prognosis is relatively good, 7 and several prognostic factors have been reported, including smoking, oral β-blocker use, the non-use of calcium channel blockers, alcohol intake, variant angina, and coronary angiography (CAG) findings such as the presence of atherosclerotic lesions, multivessel spasm (MVS), and focal spasm. 7–10 In many primary and secondary prevention studies, diabetes mellitus (DM) is listed as a significant risk factor for atherosclerotic coronary artery disease (CAD), 11–13 and CAD guidelines clearly describe the management of DM. 14 The role of DM has been reported in the pathogenesis of VSA through factors such as increased insulin resistance. 15–17 However, the impact of DM on VSA prognosis is variable, 7,8,10,18–21 although DM is addressed in the guideline of the Japanese Circulation Society (JCS). 2 Of the several factors associated with VSA prognosis, we considered focal spasm an important factor; 9,22 the presence of unstable plaques at the site of the focal spasm has also been reported. 23–25 We hypothesized that DM might have a prognostic impact on VSA, especially in the presence of focal spasm and atherosclerotic lesions. This study examined the clinical characteristics of DM in patients with VSA at the authors' hospital and investigated whether the prognostic impact of DM varies based on the presence or absence of atherosclerotic lesions and focal spasms. This retrospective study assessed 323 Japanese patients diagnosed with VSA based on CAG and spasm provocation test (SPT) results at the authors' hospital from January 2011 to -Abstract Truncated-

Prediabetic Levels of Hyperglycemia as a Predictor of Microvascular Angina with Possible Involvement of Low Levels of High-Density Lipoprotein Cholesterol and Hemoglobin

MICROVASULAR ALTERATIONS IN PREDIABETES / PRELIMINARY REPORT

Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina

Abstract P124: Human Small Artery MicroRNA Expression Profiles: Changes in Type 2 Diabetes and Associations with Endothelial Function

HbA1c is related to microcirculation blood perfusion in patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance: An observational study

Relationship between Hypertension and Mircroalbuminuria according to Obesity Status in Prediabetes

Analysis of Correlated Factors Influencing Macroangiopathy in Patients with New Onset Type 2 Diabetes Mellitus

The Significance and Risk Factor Analysis of Homocysteine in Diabetic Patients with Macroangiopathy

[Macrovascular and microvascular complications in type 2 diabetes patients]

Dysregulation of sympathoadrenal system activity in patients with microvascular angina

Diagnostic Thresholds for Pre-Diabetes Mellitus and Diabetes Mellitus and Subclinical Cardiac Disease in the General Population: Data From the ACE 1950 Study

Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes

Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank

Microvascular disease, modifiable risk factor profiles and incident arrhythmias in type 2 diabetes

microRNAs Expression, Lipid Profile, and Oxidative Stress Markers

Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes

Analysis of Angiographic Patterns in Acute Coronary Syndrome Patients With Diabetes Mellitus: Correlation With HbA1c Levels

P440 PREVALENCE OF HYPOVITAMINOSIS D OVER THE YEARS AND ITS RELATIONSHIP WITH DIABETES MELLITUS AND ANEMIA IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Associations of retinal microvascular alterations with diabetes mellitus: an OCTA-based cross-sectional study

Impact of diabetes mellitus and triglyceride glucose index on mortality and cardiovascular outcomes in patients with chronic coronary syndrome undergoing coronary computed tomography angiography